IDO1 facilitates esophageal carcinoma progression by driving the direct binding of NF-κB and CXCL10
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IDO1 facilitates esophageal carcinoma progression by driving the direct binding of NF-κB and CXCL10
Authors
Keywords
-
Journal
Cell Death Discovery
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-31
DOI
10.1038/s41420-023-01689-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual-target inhibitors of indoleamine 2, 3 dioxygenase 1 (Ido1): A promising direction in cancer immunotherapy
- (2022) Ya Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeting immunometabolism mediated by the IDO1 Pathway: A new mechanism of immune resistance in endometrial cancer
- (2022) Anna Passarelli et al. Frontiers in Immunology
- GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer
- (2021) Jin-Li Wei et al. Journal for ImmunoTherapy of Cancer
- DHX9 contributes to the malignant phenotypes of colorectal cancer via activating NF-κB signaling pathway
- (2021) Shenglan Liu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors and PROTAC-based degraders for cancer therapy
- (2021) Kai Tang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- MEST promotes lung cancer invasion and metastasis by interacting with VCP to activate NF-κB signaling
- (2021) Yang Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CXCL10 mediates breast cancer tamoxifen resistance and promotes estrogen-dependent and independent proliferation
- (2020) Xiuming Wu et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma
- (2020) Xue‐Feng Leng et al. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
- IDO Expression in Cancer: Different Compartment, Different Functionality?
- (2020) Annabel Meireson et al. Frontiers in Immunology
- IDO1 Expression in Melanoma Metastases Is Low and Associated With Improved Overall Survival
- (2020) Kevin T. Lynch et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- G9a Promotes Invasion and Metastasis of Non–Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway
- (2020) Ting Sun et al. MOLECULAR CANCER RESEARCH
- Recommendations for Tissue Microarray Construction and Quality Assurance
- (2019) Betty Glinsmann-Gibson et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Esophageal carcinoma: Towards targeted therapies
- (2019) Ali Fatehi Hassanabad et al. CELLULAR ONCOLOGY
- CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy
- (2018) Ryuma Tokunaga et al. CANCER TREATMENT REVIEWS
- IDO1 in cancer: a Gemini of immune checkpoints
- (2018) Lijie Zhai et al. Cellular & Molecular Immunology
- A TDO2-AhR Signaling Axis Facilitates Anoikis Resistance and Metastasis in Triple-Negative Breast Cancer
- (2015) Nicholas C. D'Amato et al. CANCER RESEARCH
- Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer
- (2009) Yuzo Suzuki et al. LUNG CANCER
- The Nuclear Factor NF- B Pathway in Inflammation
- (2009) T. Lawrence Cold Spring Harbor Perspectives in Biology
- High expression of indoleamine 2,3-dioxygenase gene in prostate cancer
- (2008) Chantal Feder-Mengus et al. EUROPEAN JOURNAL OF CANCER
- High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome
- (2008) M. E.D. Chamuleau et al. HAEMATOLOGICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now